Abstract
For many years, our research group worked to develop gene transfer approaches for salivary gland disorders that lacked effective conventional therapy. The purpose of this chapter is to describe and update key methods used in this process. As described in our original chapter from the 2010 volume, we focus on one clinical condition, irradiation-induced salivary hypofunction, and address the choice of transgene and vector to be used, the construction of recombinant viral vectors, how vector delivery is accomplished, and methods for assessing vector function in vitro and in an appropriate animal model.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siegel RL, Miller KD, Jemal A (2015) Cancer statistics 2015 CA. Cancer J Clin 65:5–29
Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM (2006) Sjögren’s syndrome: why autoimmune epithelitis. Oral Dis 12:523–532
Kok MR, Yamano S, Lodde BM, Wang J, Couwenhoven RI, Yakar S, Voutetakis A, Leroith D, Schmidt M, Afione S, Pillemer SR, Tsutsui MT, Tak PP, Chiorini JA, Baum BJ (2003) Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren’s syndrome. Hum Gene Ther 14:1605–1618
Baum BJ (1993) Principles of saliva secretion. Ann NY Acad Sci 694:17–23
Vitolo JM, Baum BJ (2002) The use of gene transfer for the protection and repair of salivary glands. Oral Dis 8:183–191
Preston GM, Agre P (1991) Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc Natl Acad Sci U S A 88:11110–11114
Baum BJ, Wellner RB, Zheng C (2002) Gene transfer to salivary glands. Int Rev Cytol 213:93–146
Mastrangeli A, O'Connell B, Aladib W, Fox PC, Baum BJ, Crystal RG (1994) Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am J Physiol 266:G1146–G1155
McGrory WJ, Bautista DS, Graham FL (1988) A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163:614–617
Graham FL, Smiley J, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74
Chiorini JA, Wendtner CM, Urcelay E, Safer B, Hallek M, Kotin RM (1995) High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther 6:1531–1541
Park JY, Lim BP, Lee K, Kim YG, Jo EC (2006) Scalable production of adeno- associated virus type 2 vectors via suspension transfection. Biotechnol Bioeng 94:416–430
Qu G, McClelland A, Wright JF (2000) Scaling-up production of recombinant AAV vectors for clinical applications. Curr Opin Drug Discov Devel 3:750–755
Clark KR, Voulgaropoulou F, Johnson PR (1996) A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors. Gene Ther 3:1124–1132
Conway JE, Rhys CM, Zolotukhin I, Zolotukhin S, Muzyczka N, Hayward GS, Byrne BJ (1999) High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther 6:986–993
Gao GP, Lu F, Sanmiguel JC, Tran PT, Abbas Z, Lynd KS, Marsh J, Spinner NB, Wilson JM (2002) Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap. Mol Ther 5:644–649
Urabe M, Ding C, Kotin RM (2002) Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Sene Ther 13:1935–1943
Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, Mitchell JB, Baum BJ (2004) The stable nitroxide Tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res 10:1807–1812
Cotrim AP, Hyodo F, Matsumoto K, Sowers AL, Cook JA, Baum BJ, Krishna MC, Mitchell JB (2007) Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res 13:4928–4933
Walters RW, Yi SM, Keshavjee S, Brown KE, Welsh MJ, Chiorini JA, Zabner J (2001) Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 273:20610–20616
Smith RH, Afione S, Kotin RM (2002) Transposase-mediated construction of an integrated adeno associated virus type 5 helper plasmid. Biotechniques 208:210–211
Acknowledgment
The authors’ research is supported by the intramural research program of the National Institute of Dental and Craniofacial Research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Baum, B.J., Afione, S., Chiorini, J.A., Cotrim, A.P., Goldsmith, C.M., Zheng, C. (2017). Gene Therapy of Salivary Diseases. In: Seymour, G., Cullinan, M., Heng, N. (eds) Oral Biology. Methods in Molecular Biology, vol 1537. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6685-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6685-1_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6683-7
Online ISBN: 978-1-4939-6685-1
eBook Packages: Springer Protocols